Implantica Valuation

Is IMP A SDB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IMP A SDB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IMP A SDB's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IMP A SDB's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IMP A SDB?

Key metric: As IMP A SDB barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for IMP A SDB. This is calculated by dividing IMP A SDB's market cap by their current book value.
What is IMP A SDB's PB Ratio?
PB Ratio	8.1x
Book	€109.29m
Market Cap	€903.15m

IMP A SDB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	416.2x
Enterprise Value/EBITDA	-33.1x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does IMP A SDB's PB Ratio compare to its peers?

The above table shows the PB ratio for IMP A SDB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	4.3x
SUS Surgical Science Sweden	1.7x	36.1%	SEK 7.6b
ARJO B Arjo	1.2x	25.1%	SEK 9.4b
ELOS B Elos Medtech	7.3x	n/a	SEK 5.7b
CEVI CellaVision	7x	23.4%	SEK 5.3b
IMP A SDB Implantica	8.1x	42.9%	SEK 10.4b

Price-To-Book vs Peers: IMP A SDB is expensive based on its Price-To-Book Ratio (8.1x) compared to the peer average (4.2x).

Price to Book Ratio vs Industry

How does IMP A SDB's PB Ratio compare vs other companies in the SE Medical Equipment Industry?

5 Companies	Price / Book	Estimated Growth	Market Cap
MEDF Medfield Diagnostics	0.3x	n/a	US$2.17m
BRIG Brighter	0.1x	n/a	US$2.23m
CALMA B Calmark Sweden	0.3x	n/a	US$1.08m
S2M S2Medical	0.3x	n/a	US$290.48k

5 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: IMP A SDB is expensive based on its Price-To-Book Ratio (8.1x) compared to the Swedish Medical Equipment industry average (2.2x).

Price to Book Ratio vs Fair Ratio

What is IMP A SDB's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IMP A SDB PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	8.1x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate IMP A SDB's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Arcoma

SEK 140.4m

Develops, produces, and provides radiology solutions worldwide.

ARCOMA

SEK 10.65

-2.7%

47.9%

Iconovo

SEK 76.7m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 4.82

-4.0%

-45.2%

ADDvise Group

SEK 767.8m

Supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia.

ADDV A

SEK 10.80

-10.0%

-19.4%